Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA adds surgical sponges, strips to list of shortages after Medline recall
Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives.
Cannabis use increases risk of death, heart attack for ED patients
When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.
Resilia tissue developed by Edwards Lifesciences associated with long-term durability
Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.
CCTA brings clarity, better outcomes to CTO PCI
Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.
Maggot therapy? Wrongful termination lawsuit claims nursing home had a severe sanitation problem
Boca Raton Rehabilitation Center called claims made in the lawsuit by a former employee, Nuella Joseph, “unsubstantiated.” Joseph, a nurse, said the facility has a cleanliness problem that led to bug infestations in resident rooms.

FDA adds surgical sponges, strips to list of shortages after Medline recall

Regulators said the shortages of neurosurgery devices are likely to extend until the end of the year. Medline recalled its neurosurgical patties due to a potential toxicity issue. The FDA said it's looking for alternatives.

Cannabis use increases risk of death, heart attack for ED patients

When patients land in the emergency room, a history of cannabis use may increase their risk of an adverse outcome.

Kevin Accola, MD, a cardiac surgeon at Advent Health in Orlando, Florida, explains the 10-year results from the COMMENCE aortic trial that shows long-term durability and sustained performance of its Resilia surgical aortic valve. The data were presented at the American Association for Thoracic Surgery (AATS) 2026 annual meeting this week. #AATS #AATS26 #AATS2026

Resilia tissue developed by Edwards Lifesciences associated with long-term durability

Kevin Accola, MD, spoke to Cardiovascular Business about new 10-year data on the performance of surgical valves featuring Resilia tissue. The findings are good news for Edwards Lifesciences, which also includes the tissue on many of its TAVR devices.

CCTA characterization of a chronic total occlusion with angiographic correlation during percutaneous coronary intervention.

CCTA brings clarity, better outcomes to CTO PCI

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

Maggot therapy? Wrongful termination lawsuit claims nursing home had a severe sanitation problem

Boca Raton Rehabilitation Center called claims made in the lawsuit by a former employee, Nuella Joseph, “unsubstantiated.” Joseph, a nurse, said the facility has a cleanliness problem that led to bug infestations in resident rooms.

Model in the Abiomed booth showing placement of the Impella 5.5 liters per minute catheter heart pump. This is used for patients who need more support than a conventional Impella CP can offer, but does not require level of supported from ECMO.

Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients

New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy.

First patient enrolled in massive heart failure trial

Data from BENEFIT-HF, a new randomized study of CVRx's implantable Barostim device, could open up access to many more heart failure patients.

TAVR or SAVR? Cardiologists and heart surgeons highlight the care that goes into each decision

When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.